计算结构优化增强IL13Rα2 - B7-H3联CAR T细胞,以克服抗原异质介导的瘤逃生
Michaela M Meehl1, Kalyan Immadisetty2, Vikas D Trivedi3
1Department of Bone Marrow Transplantation and Cellular Therapy (BMTCT), St. Jude Children's Research Hospital, Memphis, TN 38105, USA; College of Graduate Health Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, USA.
使用计算方法设计了一种双向的仿真抗原受体 (CAR) T细胞疗法,提高了它对抗瘤的能力. 这种优化的双重CAR T细胞疗法克服了瘤逃生机制,以更好地治疗癌症.
科学领域:
- 免疫治疗是一种免疫疗法.
- 癌症生物学 癌症生物学
- 计算生物学 计算生物学
背景情况:
- 化学抗原受体 (CAR) T细胞疗法显示对恶性瘤的疗效.
- 瘤抗原的异质性和下调使癌细胞能够逃避单一特异性的CAR T细胞.
- 针对多个抗原的Tandem CAR提供了一种克服瘤逃逸的策略.
研究的目的:
- 设计和优化IL-13Rα2-B7-H3合CAR T细胞疗法.
- 为了应对并行CAR表面表达和功能的挑战.
- 增强抗瘤疗效,对抗体异质性呈现的瘤.
主要方法:
- 系统评估 24 个协同 CAR 构造,其中包括 scFv 定位,链接器和氨基酸的变化.
- 使用计算方法识别和优化一个关键的"问题区域".
- 在体内有效性研究比较优化联CAR T细胞与单一特异的CAR T细胞.
主要成果:
- 最初的双联CAR构造未能在细胞表面表达.
- 使用计算策略的优化挽救了CAR表面表达和改进的功能.
- 优化的双联CAR T细胞在体内表现出优异的瘤清除能力,而不是单一的CAR T细胞.
结论:
- 结构引导的计算策略可以恢复表面表达,并增强协同 CAR T 细胞的抗瘤疗效.
- 计算方法对于设计像CARs这样的合成蛋白质至关重要.
- 优化的双重CAR T细胞疗法提供了一种有希望的方法来克服瘤逃逸并改善癌症治疗结果.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
相关概念视频
Tumor Immunotherapy
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cells of the Adaptive Immune Response
